Imatinib and pregnancy

J Clin Oncol. 2006 Aug 10;24(23):3812-3; author reply 3813. doi: 10.1200/JCO.2006.06.9310.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Abortion, Spontaneous / chemically induced
  • Adult
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Congenital Abnormalities / etiology
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy*
  • Pregnancy Trimesters
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Teratogens

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Teratogens
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases